Breaking News

Tweet TWEET

Amyris Gains on Deal to Develop Microorganism for BASF

Amyris Inc. (AMRS), the biotechnology company partially owned by Total SA (FP), rose after agreeing to develop a microorganism for BASF SE. (BAS)

Amyris gained 4 percent to $4.19 at the close in New York, the most since April 1.

The company, based in Emeryville, California, will develop a microorganism that produces a “relevant target molecule” for BASF, according to a statement today. Amyris didn’t say what the molecule will do or provide terms of the deal.

The companies expect the agreement to lead to other joint efforts. Amyris uses genetically modified microorganisms to convert plant sugars into fragrance oils and farnesene, a hydrocarbon that may be processed into fuels or specialty chemicals.

Total, France’s largest oil producer, owns about 18 percent of the company, according to data compiled by Bloomberg.

To contact the reporter on this story: Justin Doom in New York at jdoom1@bloomberg.net

To contact the editors responsible for this story: Reed Landberg at landberg@bloomberg.net Will Wade, Jasmina Kelemen

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.